Inhalation through Chiesi NEXThaler DPI

DEVICE2 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

AsthmaCOPD

Phase 2

An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device

CompletedNCT01651650

Chiesi Farmaceutici S.p.A.Asthma

Start: 2012-06-30End: 2012-09-30Updated: 2018-04-13

An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI

CompletedNCT02018549

Chiesi Farmaceutici S.p.A.COPD

Start: 2013-12-31End: 2014-06-30Updated: 2021-10-29